NCT01744249 2026-04-28Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine CarcinomasGrupo Espanol de Tumores NeuroendocrinosPhase 2/3 Completed256 enrolled 25 charts